Beyond Weight Loss: GLP-1 Drugs Show Promise for PMOS and Heart Health
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide, are demonstrating clinical utility beyond weight loss. In Plain English: The Clinical Takeaway Beyond Aesthetics: Patients are increasingly prescribed these … Read More